I noted previously that off-label medication use was a fiscal challenge; see Whoa Nelly (June 2025). That centered on some insurance company decisions not to "cover GLP-1s for weight loss." The impact of these potentially life-saving medications is difficult to dispute, but their cost continues to draw attention. In the interest of full disclosure, I have some investment in one of the producers, Lily.
In May 2026, NewsNation echoed a Wall Street Journal report regarding municipal governments perceiving untoward medication impacts on their budgets. Described as "sticker shock," one New England town of 15,000 residents had to rework its budget to accommodate its employees' near-million-dollar GLP-1 habit. Its conclusion was "it was nearly broke."
Some reaction was directed to "how do we pay for this," but some was also directed at "how do we stop paying for this?" There are issues associated with the financial impact on the employer, but also on the employees who desire the medication but now face increased financial responsibility.
At the outset of any discussion, obesity is an American epidemic. There have been plenty of discussions of that: Reality, Perceptions, Problems (February 2026); Obesity - a Better Definition? (June 2024); Obesity yet Again (January 2023); What is in a Name? (August 2020); Gluttony in America (August 2018); Obesity Can Kill Me? What Could Be Worse!? (March 2015); I am what I am (July 2013); Get me a Huge Soda Please (April 2013).
Undoubtedly, there are both personal and societal costs from obesity. We long ago decided to socialize American medicine in the name of compassion and fairness. Whether someone has the ability to pay for their care or not, we generally provide care. Arguments can be had regarding the extent, convenience, and efficacy of such care, but we provide some quantity nonetheless. See First Thing We Do (April 2026) and Socialized Medicine in the News (May 2026).
One of the ways we socialize medicine is through the contract of insurance. Long ago, the drive to health benefits became a rallying cry of organized labor and then an underlying cost element of various goods and services we all consume. The expense a business pays to provide employee health coverage is part of the business's calculation of how it charges for its resulting goods or services.
Is a city (or small New England town) any different?
NewsNation notes that the cost of GLP-1 medication can be "upward of $1,000 a month for people who do not have insurance coverage." There are paths around, under, and over the cost obstacles, but the meds are expensive in any event.
Municipalities are seeing competition for their budgets and will have to choose a path. They may decrease spending on other needs. A Buffalo, New York, council member noted this:
“We have crumbling infrastructure. We need new streetlights. We have parks that need investment. We need new sanitation trucks. We need more equipment for police and fire.”
The implication is that a million dollars might be spent providing GLP-1s for city employees, or the money could be used for these other perceived priorities. Despite that, the acceptance of GLP-1s seems to be expanding. France
recently announced that it would proudly be the "first country in Europe to cover" these medications. That said, their plan is to cover 65% of the cost.
At a state level, "only 13 states cover GLP-1 medications for obesity," according to
Medical News Today. The coverage that does exist "depends on your plan, your health conditions, and which GLP-1 is prescribed." The tenor of that article suggests coverage can be sparse and challenging.
The impacts are potentially the same for workers' compensation (WC) budgets. Many view workers' compensation responsibility as limited to workplace exposures or accidents. Nonetheless, it is common for such programs to treat co-morbidities and interrelated health challenges that impact the work injury recovery. GLP-1 are likely being provided in some state WC systems for weight loss and diabetes. Thus, the cost challenges are likely there as well.
The equation is not different for the employees. They perceive a personal need for weight loss and all the benefits that it provides. Having lost a great deal of weight in my golden years, I personally attest to the benefits in fitness, energy, and well-being.
An employee quoted in the
NewsNation article was shocked when her insurance plan changed. She noted that she had been responsible for a $30-per-month copay for her GLP-1, but she lost her coverage for this medication. She now finds herself, seemingly, faced with the reality of paying $300 per month for another version. That change will stretch a family budget. Like cities, every family has competing interests to fund: food, shelter, etc.
Notably, there is no mention in the
NewsNation article of the alternatives to GLP-1. The simple fact is that when we consume fewer calories than we burn, weight loss follows. I know this as I have done it. The equation is simple. To accomplish the feat, one may eat less while maintaining activity. Or, one may eat the same while increasing activity. Or, for the real results, one can increase activity while decreasing caloric intake.
Eating less costs less (budget-friendly). Exercise need not involve a membership or even much equipment; I walked my weight off with some $40.00 per pair. close-out, running shoes. I go through about two pairs per year. They are not pretty, but they offer the support I need. Since reaching my goal weight, I walk two miles every morning, rain or shine.
I watch my step counter, and with my other daily activities and periodic walks, I average more like 3.5 miles daily. I take the stairs every day, each way. Little changes can make a big difference, and at little to no financial cost.
Could employers be as creative? Do employers provide opportunities for activity? I know people who walk twice a day with their coworkers. They (1) socialize, (2) often discuss work challenges, (3) clear their minds, and (4) get almost a mile of steps each morning and afternoon. The employer may see that as 30 minutes of lost productivity daily. But they might as readily see it as promoting health, team, and well-being.
There are no easy answers. I struggled with weight for decades without the success or even motivation for it. Lives are busy, and there is a draw to the easy answer of a pill. But in the end, the success comes from lifestyle change. The equation between calories consumed and burned will remain, whether a decrease in consumption is motivational or pharmaceutical.
And there are budget considerations for everyone involved.
